Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - RESEARCH & DEVELOPMENT
Research & Development ALNY - Alnylam Pharmaceuticals, Inc.
1 B
LAST VALUE
12.60%
2 YEAR CAGR
14.72%
5 YEAR CAGR
24.42%
10 YEAR CAGR